ASS1 and cancer: Here, the median PFS and OS were 4.2 (95% confidence interval: 2.9–4.8) and 7.2 (95% confidence interval: 5.1–18.4) months, respectively, and consistent with the poor prognosis of ASS1-deficient cancers.15